Huzhou Shenke is a developer of biological product quality testing tools. The company has long been focusing on the R&D, production, sales and technical services of common key technologies and products in the field of biological product quality and safety, providing host cell nucleic acid, protein and sugar residues, exogenous Factors, process residues, genetic stability and other detection technology services and standardized detection kits, with independent intellectual property rights, are domestic GMP and GLP biopharmaceutical biosafety quality control detection reagents and technical service providers. Huzhou Shenke recently completed its B round of financing. This round of financing was jointly led by CITIC and CICC, and specifically included “funds under CICC Capital, CITIC Securities Investment, Goldstone Investment, CLSA Capital, Sunshine Ronghui, and Huzhou Talent Innovation Fund” and other institutions. The funds raised in this round will be mainly used for technology research and development investment and production capacity building, including the construction of Shanghai R&D center, product line expansion and expansion, and the introduction of innovation and management talents.
This article is transferred from: https://www.itjuzi.com/investevent/13785979
This site is only for collection, and the copyright belongs to the original author.